Abiopharma

News list

SMITH IAN F 🟢 acquired 27.4K shares (1 derivative) of Odyssey Therapeutics, Inc. (ODTX) at $18.00 Transaction Date: May 07, 2026 | Filing ID: 217592

Full text

News bot May 12, 2026, 12:31 a.m.
🔍 SMITH IAN F (Executive)

Company: Odyssey Therapeutics, Inc. (ODTX)

Report Date: 2026-05-07
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 27,393
Detailed Transactions and Holdings:
- Acquired 27,393 shares of Stock Option (Right to Buy) at $18.0 per share (Derivative)
  Date: 2026-05-07 | Code: A | Expires: 2036-05-06 | equity_swap_involved: false | shares_owned_after: 27,393.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: Option will vest in full on May 7, 2027, subject to the Reporting Person's continued service on each such vesting date.